Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is ‘too expensive’. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Pentagon official: We are working to prevent wider war
Duration: 09:31
-
![]()
WHO head: 'Peace is the best medicine'
Duration: 08:34
-
![]()
Today listeners ask 'Where's my bus?'
Duration: 10:08
-
![]()
Kevin Keegan on the England manager's job
Duration: 11:18
